Renaissance Technologies
HRMY icon

Renaissance Technologies’s Harmony Biosciences HRMY Stock Holding History

Renaissance Technologies’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.5M Buy
1,195,371
+118,000
+11% +$3.72M 0.06% 382
2026
Q1 		$30.2M Buy
1,077,371
+6,900
+0.6% +$226K 0.05% 494
2025
Q4 		$40.1M Sell
1,070,471
-66,600
-6% -$2.19M 0.06% 350
2025
Q3 		$31.3M Buy
1,137,071
+207,600
+22% +$7.15M 0.04% 533
2025
Q2 		$29.4M Buy
929,471
+89,100
+11% +$2.87M 0.04% 552
2025
Q1 		$27.9M Buy
840,371
+271,700
+48% +$9.74M 0.04% 527
2024
Q4 		$19.6M Buy
568,671
+76,071
+15% +$2.61M 0.03% 680
2024
Q3 		$19.7M Sell
492,600
-103,200
-17% -$3.62M 0.03% 672
2024
Q2 		$18M Buy
595,800
+215,700
+57% +$6.49M 0.03% 644
2024
Q1 		$12.8M Buy
380,100
+121,600
+47% +$3.9M 0.02% 862
2023
Q4 		$8.35M Sell
258,500
-33,600
-12% -$938K 0.01% 1038
2023
Q3 		$9.57M Sell
292,100
-118,300
-29% -$4.11M 0.02% 948
2023
Q2 		$14.4M Sell
410,400
-55,400
-12% -$1.91M 0.02% 837
2023
Q1 		$15.2M Buy
465,800
+123,100
+36% +$5.61M 0.02% 866
2022
Q4 		$18.9M Buy
342,700
+17,700
+5% +$973K 0.03% 734
2022
Q3 		$14.4M Buy
325,000
+33,200
+11% +$1.62M 0.02% 841
2022
Q2 		$14.2M Buy
291,800
+149,300
+105% +$6.72M 0.02% 915
2022
Q1 		$6.93M Buy
142,500
+7,700
+6% +$314K 0.01% 1369
2021
Q4 		$5.75M Buy
134,800
+95,400
+242% +$3.8M 0.01% 1439
2021
Q3 		$1.51M Buy
39,400
+27,600
+234% +$889K ﹤0.01% 2306
2021
Q2 		$333K Buy
+11,800
New +$354K ﹤0.01% 3109

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies's HRMY Position: Q2 2026 in Review

Renaissance Technologies increased its Harmony Biosciences (HRMY) stake by 11% in Q2 2026, buying an estimated $3.72M and bringing the position to 1,195,371 shares worth $43.5M. The position accounts for 0.06% of the portfolio, ranked #382.

Renaissance Technologies first reported a position in HRMY in Q2 2021 and has held it in 21 quarters since. 326 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Renaissance Technologies held 1,195,371 shares of Harmony Biosciences worth $43.5M as of Q2 2026.
  • Renaissance Technologies bought 118,000 Harmony Biosciences shares in Q2 2026, an estimated $3.72M.
  • Harmony Biosciences made up 0.06% of Renaissance Technologies's portfolio in Q2 2026, its #382 holding.
  • Renaissance Technologies first reported a position in Harmony Biosciences in Q2 2021 and has held it in 21 quarters since.
  • 326 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.